OrbiMed’s Mural Oncology MURA Stock Holding History
Bought
Maintained
Sold
OrbiMed's MURA Position: Q4 2025 in Review
OrbiMed sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 588,800 shares — an estimated $1.22M sold.
OrbiMed first reported a position in MURA in Q2 2025 and held it in 2 quarters. The position peaked at $1.45M in Q2 2025. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.
- OrbiMed reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
- OrbiMed sold 588,800 Mural Oncology shares in Q4 2025, an estimated $1.22M.
- OrbiMed first reported a position in Mural Oncology in Q2 2025 and held it in 2 quarters.
- OrbiMed's Mural Oncology position peaked at $1.45M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.
Based on OrbiMed's 13F filing for Q4 2025, filed 17 Feb 2026.